Disarmament Diplomacy
Issue No. 23, February 1998
The Biological Weapons Convention (BWC):
Remarks by ACDA Director
Press Conference with John D. Holum, Director, US Arms
Control and Disarmament Agency (ACDA), Bonn, Germany, 11 February
1998
Extracts from Remarks
"I am here to work at addressing a gap in our capabilities to
deal with weapons of mass destruction. In the recent past, we have
made enormous strides in the international community to address the
growing threat in the post-Cold War era of weapons of mass
destruction, nuclear and chemical and biological weapons and
delivery systems.
We have negotiated a Comprehensive Test Ban treaty, we have
extended the Nuclear Non-Proliferation Treaty and made it
permanent. We have negotiated and now have in force the Chemical
Weapons Convention. There is one glaring gap in that coverage, and
that is an effective enforcement regime for the Biological Weapons
Convention of 1972.
Biological weapons are very frequently grouped with chemical
weapons. In my judgment, given their destructive potential, they
should more appropriately be considered akin to nuclear weapons.
Chemical weapons, for all of their toxicity and danger, when they
are dispersed, become less toxic. Biological weapons in the right
environment can actually multiply, self-perpetuate and even mutate
to defeat protective measures. The biological agent, botulinum, has
been estimated to be three million times as toxic as the chemical
nerve agent sarin. A particle of anthrax the size of a particle of
dust could be fatal. The current events in Iraq and Saddam
Hussein's long-standing interest, going back to the 1970s, to
develop a biological weapons capability just underscores the
importance of the international community dealing effectively with
biological weapons.
The President, in his State of the Union address, underscored
the fact that the danger posed by biological weapons in the hands
of rogue States and potentially in the hands of terrorists, is
increasing. He said in that address, to prevent the use of disease
as weapons of war and terror, the international community has to
act now. The Biological Weapons Convention, he said, has been in
effect for twenty-three years. The rules are good, but the
enforcement is weak. We must strengthen it with a new international
inspection system to detect and deter cheating.
... The United States is committed to developing a legally
binding protocol that will help prevent the proliferation of these
weapons and help catch countries that attempt to cheat on their
obligations under the treaty. I am here in Germany to follow up on
the President's State of the Union address in which he, in
associated documents, laid out some new initiatives to try to
energize the negotiations that have been under way since 1995 in
Geneva in the hopes that we can complete the framework to the
protocol to the convention, an enforcement protocol, by the end of
this year."
Extracts from Questions-and Answers
"Question: 'Please elaborate a little on the initiatives
you are talking about here in Bonn with the representatives of the
government. Can you do that please?'
Holum: 'Sure. One of the issues in the Biological Weapons
Convention is the extent of inspection activity. We believe that
the regime must include not just, as we have now, voluntary
disclosure, but mandatory declarations of relevant facilities. We
think there should be a series of different kinds of on-site
activity ranging from voluntary visits by inspectors, to relevant
activities, through clarification visits of some kind that would
answer questions pertaining to a country's declaration. And, of
course, on-site challenge inspections. This is a very complex area
because there are literally thousands of sites that would likely be
declared around the world that arguably have the capacity to
produce biological weapons, but are in operation for legitimate
medical or commercial or other purposes. What we have to do is find
the right balance that strengthens enforcement and gives
international inspectors a fair chance of detecting cheating and
clarifying ambiguities but, at the same time, avoid steps that
would endanger legitimate national security information or
proprietary business information. ...'
Question: 'Why all of a sudden right now? Why not do it,
what is the reason for this now? Is Germany the first stop?'
Holum: 'Germany is the first stop on this trip. I'll also
be going to the UK and France now, in part, because the President
has directed a renewed impetus. We have been engaged in this
negotiation since 1995 so it is not new, but what we have found
during the course of those discussions is it is fairly easy to get
bogged down in technical details. There are a number of country
groups that have differing perspectives, and I think the
President's speech gave us new impetus, both in terms of his
personal interest and his direction that we develop new ideas to
bridge some of the gaps among different countries. This gives us a
good chance to stimulate the negotiations and move forward.
We have also, in the context of the discussions in Geneva among
the member countries, intensified the work steadily. Last year, we
had nine weeks of work. I think this year it will be eleven,
including another session in March, additional more intense work
schedule plus a lot of consultation in between.
I mentioned that I think the situation in Iraq concentrates the
mind as well. This is one of the areas where Iraq has been most
determined to pursue weapons of mass destruction and has been least
forthcoming in its declarations.'
Question: 'German enterprises have been engaged in
helping Saddam Hussein to build up factories for chemical weapons.
Do you know anything about, maybe German enterprises that are
helping him in constructing biological weapons?'
Holum: 'I haven't seen any reporting to that effect. I
think one of the difficulties that we face in this area, and it
reveals the gaps in coverage, is that the international community,
and I wouldn't single out any country, has been slow to apply
effective export control mechanisms. The Australia Group, of which
Germany is a member as well as the United States, is twenty-nine
countries total. It is actively engaged in cooperating to control
both chemical and biological weapons technology and substances. It
has grown progressively stronger. But the international community
has been trying to catch up with the danger of the spread of,
particularly, chemical and biological weapons. There are a lot of
countries, I suspect, that have had in the past, export and
business relationships with Iraq, Iran and others that they would
have just as soon have foregone, looking at the direction that
those programs have taken. That is true of the United States as
well.' ...
Question: 'Do you know how many countries are producing
and storing biological weapons or are making experiments with these
weapons?'
Holum: 'It is hard to quantify and I can't go into a
great deal of detail without getting into intelligence information.
The sum of the chemical and biological weapons interested countries
with varying degrees of activity is roughly 25. That's countries
that have the capability and we believe have some kind of chemical
and/or biological weapons capability.'"
© 1998 The Acronym Institute.
Return to top of page
Return to List of Contents
Return to Acronym Main Page
|